|
Molecular mechanisms of prostate cancer metastasis
|
5R01CA183929-04
|
$366,000
|
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Mechanisms Underlying Functional Programs of Tumor-Associated Macrophages
|
5R01CA172105-04
|
$401,456
|
|
ABRAMS, SCOTT
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
tDCS for Increasing Exercise Adherence in Individuals with Elevated Depressive Symptoms
|
5R21CA214102-02
|
$154,969
|
|
ABRANTES, ANA
|
BUTLER HOSPITAL (PROVIDENCE, RI)
|
|
Genotype and Imaging Phenotype Biomarkers in Lung Cancer
|
5U01CA190234-04
|
$659,886
|
|
AERTS, HUGO
|
DANA-FARBER CANCER INST
|
|
Genetic Dissection of Acute Myeloid Leukemia.
|
5R01CA169784-05
|
$355,993
|
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Nucleotide Metabolism in Senescence and Platinum Resistance of Ovarian Cancer
|
5R00CA194309-04
|
$210,465
|
|
AIRD, KATHERINE
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
|
Regulation of mitosis by proteolysis in yeast
|
5R01CA206157-23
|
$289,175
|
|
AMON, ANGELIKA
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Novel Dual Notch/PXR Targeting for Colon Cancer Therapy
|
5R01CA182872-05
|
$661,842
|
|
ANANT, SHRIKANT
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
|
Image guided immunotherapy and targeted radionuclide therapy of metastatic melanoma
|
5R01CA214018-02
|
$481,065
|
|
ANDERSON, CAROLYN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Development of whole-brain in vivo 2HG imaging for precision medicine in mutant IDH glioma
|
5R01CA211080-02
|
$530,585
|
|
ANDRONESI, OVIDIU
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Leukemia Specific Splice Isoforms as Neo-Antigens for T-Cell Immunotherapy
|
5R01CA201225-03
|
$490,809
|
|
ARMISTEAD, PAUL
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Childhood Cancer Survivor Study
|
5U24CA055727-24
|
$4,218,764
|
|
ARMSTRONG, GREGORY
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Personalized vaccine for patients with AML
|
5R01CA212649-02
|
$721,179
|
|
AVIGAN, DAVID
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Radiolabeled FASN Inhibitors for PET Imaging
|
5R21CA213157-02
|
$176,883
|
|
BABICH, JOHN
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
Biophotonics to Couple Pancreatic with Upper GI Screening via Ultrathin Endoscopy
|
5R01CA183101-04
|
$620,486
|
|
BACKMAN, VADIM
|
NORTHWESTERN UNIVERSITY
|
|
DNA damage signaling to immune checkpoints
|
5R01CA204173-02
|
$376,715
|
|
BAKKENIST, CHRISTOPHER
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
IKK/NF-kappaB Signaling in Cancer: Therapy, Resistance, and Tumor Initiating Cells
|
5R35CA197684-03
|
$848,325
|
|
BALDWIN, ALBERT
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Systems genetics analysis of tumor evolution in the mouse
|
5R35CA210018-02
|
$951,000
|
|
BALMAIN, ALLAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Catch and Release Immunotoxins: CAR-Bombs for Cancer
|
5R01CA204192-02
|
$360,914
|
|
BALTHASAR, JOSEPH
|
STATE UNIVERSITY OF NEW YORK AT BUFFALO
|
|
Contribution of development and age to breast cancer etiology
|
5R01CA190980-04
|
$569,421
|
|
BARCELLOS-HOFF, MARY
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Developing a Decision Aid for Adolescent and Young Adult Female Cancer Survivors Considering Future Family-Building after Treatment
|
5R03CA212924-02
|
$82,500
|
|
BENEDICT, CATHERINE
|
FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
|
|
Role of KDM5A in pRB-mediated differentiation
|
5R01CA211095-02
|
$372,740
|
|
BENEVOLENSKAYA, ELIZAVETA
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
Investigating the role of the small GTPase RIT1 in lung adenocarcinoma
|
5R00CA197762-04
|
$249,000
|
|
BERGER, ALICE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Metabolic liabilities of cancer cells to the tumor nutrient environment
|
5K22CA193660-03
|
$130,032
|
|
BIRSOY, KIVANC
|
ROCKEFELLER UNIVERSITY
|
|
The sequence recognition, structure and function of the IMP family of mRNA binding proteins
|
5F30CA214009-02
|
$49,524
|
|
BISWAS, JEETAYU
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Targeting Wnt signaling to overcome PARP inhibitor resistance in ovarian cancer
|
5R00CA194318-04
|
$249,001
|
|
BITLER, BENJAMIN
|
UNIVERSITY OF COLORADO DENVER
|
|
Optimizing biologically-based rational polytherapy in ALK+ lung cancer
|
5R01CA211052-02
|
$362,569
|
|
BIVONA, TREVER
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Regulatory Validation of Standardized Clinical Laboratory Immunohistochemistry Controls
|
5R44CA213476-02
|
$751,890
|
|
BOGEN, STEVEN
|
MEDICAL DISCOVERY PARTNERS, LLC
|
|
Intraoperative Polarization-Sensitive OCT for Assessing Breast Tumor Margins
|
5R01CA213149-02
|
$475,541
|
|
BOPPART, STEPHEN
|
UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
|
|
The role of paracrine WNT5A/RYK in ErbB2-driven tumorigenesis
|
5F30CA206255-02
|
$34,447
|
|
BORCHERDING, NICHOLAS
|
UNIVERSITY OF IOWA
|
|
Regulatory T Cell Control of Intestinal Tumorigenesis
|
5R01CA168670-05
|
$345,488
|
|
BOTHWELL, ALFRED
|
YALE UNIVERSITY
|
|
Experimental study of stress and DNA damage in humans: Mediators and moderators
|
5R01CA211371-02
|
$420,080
|
|
BOVBJERG, DANA
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Leukocyte telomere length in bladder cancer survivors: Diet and exercise trial
|
5R21CA212628-02
|
$203,580
|
|
BOVBJERG, DANA
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Group Health Cancer Research Program Research Specialist Award
|
5R50CA211115-03
|
$183,884
|
|
BOWLES, ERIN
|
KAISER FOUNDATION RESEARCH INSTITUTE
|
|
Exploitation of RAS signaling to develop therapy and early detection strategies for PDA
|
5R01CA192381-04
|
$454,817
|
|
BREKKEN, ROLF
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Targeting HuR to improve a synthetic lethal therapy for pancreatic cancer
|
5R01CA212600-02
|
$372,748
|
|
BRODY, JONATHAN
|
THOMAS JEFFERSON UNIVERSITY
|
|
Role of the macrophage derived XL313 epitope in angiogenesis and tumor growth
|
5R01CA196739-02
|
$356,850
|
|
BROOKS, PETER
|
MAINE MEDICAL CENTER
|
|
Center for Native Population Health Disparities
|
1P50CA148110-01
|
$1,911,941
|
$19,119
|
BUCHWALD, DEDRA
|
UNIVERSITY OF WASHINGTON
|
|
Randomized Trial of Workplace Interventions to Improve Health of Alaska Natives
|
5R01CA126620-04
|
$319,291
|
$319,291
|
BUCHWALD, DEDRA
|
UNIVERSITY OF WASHINGTON
|
|
USP7 inhibitors for the treatment of multiple myeloma
|
5R01CA211681-02
|
$504,721
|
|
BUHRLAGE, SARA
|
DANA-FARBER CANCER INST
|
|
Targeting APOBEC3A-expressing cancer cells with ATR inhibitors
|
5K99CA212154-02
|
$142,027
|
|
BUISSON, REMI
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Effects of Photodynamic Therapy on Tumor Oxygenation and Blood Flow
|
5R01CA085831-15
|
$324,000
|
|
BUSCH, THERESA
|
UNIVERSITY OF PENNSYLVANIA
|
|
Breast Cancer Cell Dormancy is Orchestrated by Stroma & Tissue Microenvironment
|
5R00CA178177-05
|
$249,000
|
|
BUSSARD, KAREN
|
THOMAS JEFFERSON UNIVERSITY
|
|
Molecular Evaluation of Targeted Therapies in Lymphoid Malignancies
|
5R01CA183444-05
|
$501,285
|
|
BYRD, JOHN
|
OHIO STATE UNIVERSITY
|
|
Mobile contingency management for smoking cessation in returning US Veterans
|
5R01CA196304-04
|
$327,035
|
|
CALHOUN, PATRICK
|
DUKE UNIVERSITY
|
|
A novel point of care test for oral and oropharyngeal cancer risk
|
5R01CA204264-02
|
$554,293
|
|
CALIFANO, JOSEPH
|
UNIVERSITY OF CALIFORNIA, SAN DIEGO
|
|
Molecular Mechanisms of Tumor Behavior and Response to Therapy in HPV-positive Oropharyngeal Cancer
|
5R01CA194536-03
|
$483,596
|
|
CAREY, THOMAS
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Using extracellular metabolites to understand and revert protumoral effects of Tumor-Associated Macrophages
|
5R00CA191021-04
|
$249,000
|
|
CARMONA-FONTAINE, CARLOS
|
NEW YORK UNIVERSITY
|
|
Development of molecular probes to investigate and drug the oncogenic Wnt/?-catenin/BCL9/B9L transcriptional complex
|
1R21CA221683-01
|
$229,576
|
|
CARRASCO, RUBEN
|
DANA-FARBER CANCER INST
|
|
Inherited colorectal cancer risk variants: from association to biology
|
5R01CA143237-08
|
$774,494
|
|
CASEY, GRAHAM
|
UNIVERSITY OF VIRGINIA
|
Total relevant funding to Arctic for this search: $1,236,016
|